HidayatL. K.,
HsuD. I.,
QuistR.,
ShrinerK. A.,
Wong-BeringerA.2006; High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166:2138–2144[CrossRef]
HoP. L.,
LoP. Y.,
ChowK. H.,
LauE. H.,
LaiE. L.,
ChengV. C.,
KaoR. Y.2010; Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. J Infect 60:140–145[CrossRef]
HsuD. I.,
HidayatL. K.,
QuistR.,
HindlerJ.,
KarslssonA.,
YusofA.,
Wong-BeringerA.2008; Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of methicillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 32:378–385[CrossRef]
LodiseT. P.,
GravesJ.,
EvansA.,
GraffunderE.,
HelmeckeM.,
LomaestroB. M.,
StellrechtK.2008; Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteraemia treated with vancomycin. Antimicrob Agents Chemother 52:3315–3320[CrossRef]
MoiseP. A.,
SmythD. A.,
El-FawalN.,
RobinsonD. A.,
HoldenP. N.,
ForrestA.,
SakoulasG.2008; Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 61:85–90
PrakashV.,
LewisJ. S.,
JorgensenJ. H.2008; Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother 52:4528[CrossRef]
RobertJ.,
BismuthR.,
JarlierV.2006; Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus : a 20 year study in a large French teaching hospital, 1983–2002. J Antimicrob Chemother 57:506–510[CrossRef]
SaderH. S.,
RhombergP. R.,
JonesR. N.2009; Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus
. Antimicrob Agents Chemother 53:3162–3165[CrossRef]
SakoulasG.,
Moise-BroderP. A.,
SchentagJ.,
ForestA.,
MoelleringR. C.,
EliopoulosG. M.2004; Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteraemia. J Clin Microbiol 42:2398–2402[CrossRef]
WalshT. R.,
BolmströmA.,
QwärnströmA.,
HoP.,
WoottonM.,
HoweR. A.,
MacGowanA. P.,
DiekemaD.2001; Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 39:2439–2444[CrossRef]
WangG.,
HindlerJ. F.,
WardK. W.,
BrucknerD. A.2006; Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 44:3883–3886[CrossRef]